Japan Adds 12 Drugs To NHI Price List; Takeda Takes Four, Pfizer, Alexion Also Gain
This article was originally published in PharmAsia News
Executive Summary
Japan's Central Social Medical Insurance Agency (Chuikyo) June 2 approved the addition of 29 products of 12 ingredients. Among them, six are new chemical entities, four are new combinations and two are new administration routes with one additional indication and dosage